Functional results -- including improvement of International Prostate Symptom Score ( IPSS ) , quality of life ( QOL ) , peak urinary flow , postvoiding residual urine volume , prostate-specific antigen ( PSA ) level , and prostate volume -- were assessed at @ - , @ - , @ - , @ - , and @-month follow-up between January @ , @ , and January @ , @ .